Back to search
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hydroxymethylglutaryl-CoA Reductase Inhibitors trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hydroxymethylglutaryl-CoA Reductase Inhibitors trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of the ASA-3C trial is to evaluate the role of aspirin and high-intensity statin therapy, respectively, in individuals with severe coronar…
Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and ado…
This study aims to investigate how different types and intensities of exercise affect muscle recovery in individuals taking statin medications compared to healt…
The purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypercholesterolemia with inadequate lipid control on statins plus…
The ULTRA-CKD trial is a prospective, randomized, open-label, multicenter trial designed to compare the efficacy and safety of moderate-intensity statin plus ez…
The goal of this observational study is to learn about the safety and effects of atorvastatin in treatment of Chinese Kawasaki disease (KD) children complicated…
For Patients and Families Brief Title: Management of 1L Lorlatinib with Hyperlipidemia in ALK+ Advanced NSCLC What is this study about? This study is for peo…
The purpose of this project is to identify the minimum effective dose (MED) of a multi-component behavioral change intervention required to increase levels of p…